Cargando…
Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial
Bifidobacterium animalis subsp. lactis HN019 (HN019) ameliorates chronic idiopathic constipation. Our aim was to determine the efficacy and safety of 28-day supplementation with 1 × 10(9) or 1 × 10(10) CFU of HN019/day for constipation. A total of 228 adults who were diagnosed with functional consti...
Autores principales: | Ibarra, Alvin, Latreille-Barbier, Mathilde, Donazzolo, Yves, Pelletier, Xavier, Ouwehand, Arthur C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219592/ https://www.ncbi.nlm.nih.gov/pubmed/29227175 http://dx.doi.org/10.1080/19490976.2017.1412908 |
Ejemplares similares
-
Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review
por: Cheng, Jing, et al.
Publicado: (2021) -
Use of the Probiotic Bifidobacterium animalis subsp. lactis HN019 in Oral Diseases
por: Araujo, Lisa Danielly Curcino, et al.
Publicado: (2022) -
The Effect of Delivery Matrix on Bifidobacterium animalis subsp. lactis HN019 Survival through In Vitro Human Digestion
por: Yeung, Nicolas, et al.
Publicado: (2023) -
Effects of oral administration of Bifidobacterium animalis subsp. lactis HN019 on the treatment of plaque-induced generalized gingivitis
por: de Almeida Silva Levi, Yara Loyanne, et al.
Publicado: (2022) -
Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials
por: Rasinkangas, Pia, et al.
Publicado: (2022)